LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | BX-912 | 3.33 | uM | LJP5 | 2 | L20 | 72 | hr | 1097 | 3635 | 3877 | 0.9374 | 0.9303 |
BT-20 | BX-912 | 3.33 | uM | LJP5 | 3 | L20 | 72 | hr | 1097 | 3731 | 3925 | 0.9505 | 0.9455 |
BT-20 | BX-912 | 10 | uM | LJP5 | 1 | L19 | 72 | hr | 1097 | 2370 | 3735 | 0.6345 | 0.5461 |
BT-20 | BX-912 | 10 | uM | LJP5 | 2 | L19 | 72 | hr | 1097 | 2344 | 3877 | 0.6045 | 0.5170 |
BT-20 | BX-912 | 10 | uM | LJP5 | 3 | L19 | 72 | hr | 1097 | 2161 | 3925 | 0.5505 | 0.4457 |
BT-20 | Selumetinib | 0.04 | uM | LJP6 | 1 | M12 | 72 | hr | 1097 | 3597 | 3610 | 0.9962 | 0.9956 |
BT-20 | Selumetinib | 0.04 | uM | LJP6 | 2 | M12 | 72 | hr | 1097 | 3837 | 3713 | 1.0332 | 1.0375 |
BT-20 | Selumetinib | 0.04 | uM | LJP6 | 3 | M12 | 72 | hr | 1097 | 3694 | 3696 | 0.9993 | 0.9993 |
BT-20 | Selumetinib | 0.12 | uM | LJP6 | 1 | M11 | 72 | hr | 1097 | 3238 | 3610 | 0.8968 | 0.8772 |
BT-20 | Selumetinib | 0.12 | uM | LJP6 | 2 | M11 | 72 | hr | 1097 | 3699 | 3713 | 0.9960 | 0.9955 |
BT-20 | Selumetinib | 0.12 | uM | LJP6 | 3 | M11 | 72 | hr | 1097 | 3325 | 3696 | 0.8995 | 0.8827 |
BT-20 | Selumetinib | 0.37 | uM | LJP6 | 1 | M10 | 72 | hr | 1097 | 3682 | 3610 | 1.0198 | 1.0229 |
BT-20 | Selumetinib | 0.37 | uM | LJP6 | 2 | M10 | 72 | hr | 1097 | 3431 | 3713 | 0.9239 | 0.9120 |
BT-20 | Selumetinib | 0.37 | uM | LJP6 | 3 | M10 | 72 | hr | 1097 | 3500 | 3696 | 0.9469 | 0.9386 |
BT-20 | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 1097 | 3716 | 3610 | 1.0292 | 1.0338 |
BT-20 | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 1097 | 3321 | 3713 | 0.8943 | 0.8769 |
BT-20 | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 1097 | 3632 | 3696 | 0.9826 | 0.9800 |
BT-20 | Selumetinib | 3.33 | uM | LJP6 | 1 | M08 | 72 | hr | 1097 | 3243 | 3610 | 0.8982 | 0.8789 |
BT-20 | Selumetinib | 3.33 | uM | LJP6 | 2 | M08 | 72 | hr | 1097 | 3301 | 3713 | 0.8889 | 0.8704 |
BT-20 | Selumetinib | 3.33 | uM | LJP6 | 3 | M08 | 72 | hr | 1097 | 3538 | 3696 | 0.9571 | 0.9506 |
BT-20 | Selumetinib | 10 | uM | LJP6 | 1 | M07 | 72 | hr | 1097 | 3540 | 3610 | 0.9805 | 0.9772 |
BT-20 | Selumetinib | 10 | uM | LJP6 | 2 | M07 | 72 | hr | 1097 | 3277 | 3713 | 0.8824 | 0.8627 |
BT-20 | Selumetinib | 10 | uM | LJP6 | 3 | M07 | 72 | hr | 1097 | 3090 | 3696 | 0.8359 | 0.8056 |
BT-20 | MK2206 | 0.04 | uM | LJP6 | 1 | F06 | 72 | hr | 1097 | 3405 | 3610 | 0.9431 | 0.9329 |
BT-20 | MK2206 | 0.04 | uM | LJP6 | 2 | F06 | 72 | hr | 1097 | 3164 | 3713 | 0.8520 | 0.8259 |